Search research articles
Contact Us
Filters
Showing results (111-120 of 125) with videos related to
Page
of 13
Sort By:
Journal of the National Cancer Institute
|
May 26, 1999
Impact of the treating institution on survival of patients with "poor-prognosis" metastatic nonseminoma. European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group and the Medical Research Council Testicular Cancer Working Party
L Collette, R J Sylvester, S P Stenning, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 16, 2002
An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study
G M Mead, M R Sydes, J Walewski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 1998
Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council/European Organization for Research and Treatment of Cancer study
S B Kaye, G M Mead, S Fossa, et al.
British Journal of Cancer
|
December 6, 2000
A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party
A Horwich, R T Oliver, P M Wilkinson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 1998
Filgrastim during combination chemotherapy of patients with poor-prognosis metastatic germ cell malignancy. European Organization for Research and Treatment of Cancer, Genito-Urinary Group, and the Medical Research Council Testicular Cancer Working Party, Cambridge, United Kingdom
S D Fosså, S B Kaye, G M Mead, et al.
Cancer
|
October 8, 1998
Postchemotherapy residual masses in germ cell tumor patients: content, clinical features, and prognosis. Medical Research Council Testicular Tumour Working Party
S P Stenning, M C Parkinson, C Fisher, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 1, 1997
Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapy
S D Fosså, R T Oliver, S P Stenning, et al.
Cancer
|
September 26, 2000
A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma: cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy
G M Mead, N M Bleehen, A Gregor, et al.
Lancet (London, England)
|
July 26, 2005
Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial
R T D Oliver, M D Mason, G M Mead, et al.
British Journal of Cancer
|
June 2, 2005
Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours: a prospective trial (MRC TE17)
D P Dearnaley, S D Fossa, S B Kaye, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 125) with videos related to
Sort By:
Page
of 13
Journal of the National Cancer Institute
|
May 26, 1999
Impact of the treating institution on survival of patients with "poor-prognosis" metastatic nonseminoma. European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group and the Medical Research Council Testicular Cancer Working Party
L Collette, R J Sylvester, S P Stenning, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 16, 2002
An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study
G M Mead, M R Sydes, J Walewski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 1998
Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council/European Organization for Research and Treatment of Cancer study
S B Kaye, G M Mead, S Fossa, et al.
British Journal of Cancer
|
December 6, 2000
A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party
A Horwich, R T Oliver, P M Wilkinson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 1998
Filgrastim during combination chemotherapy of patients with poor-prognosis metastatic germ cell malignancy. European Organization for Research and Treatment of Cancer, Genito-Urinary Group, and the Medical Research Council Testicular Cancer Working Party, Cambridge, United Kingdom
S D Fosså, S B Kaye, G M Mead, et al.
Cancer
|
October 8, 1998
Postchemotherapy residual masses in germ cell tumor patients: content, clinical features, and prognosis. Medical Research Council Testicular Tumour Working Party
S P Stenning, M C Parkinson, C Fisher, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 1, 1997
Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapy
S D Fosså, R T Oliver, S P Stenning, et al.
Cancer
|
September 26, 2000
A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma: cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy
G M Mead, N M Bleehen, A Gregor, et al.
Lancet (London, England)
|
July 26, 2005
Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial
R T D Oliver, M D Mason, G M Mead, et al.
British Journal of Cancer
|
June 2, 2005
Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours: a prospective trial (MRC TE17)
D P Dearnaley, S D Fossa, S B Kaye, et al.
Page
of 13